SynthesisCancer causes & control : CCC2026

Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.

Parnian Kheirkhah Rahimabad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.